Gland Pharma

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,600.45",
    "chg": -17.05,
    "chgp": "-0.65%",
    "dir": -1,
    "prev_price": "2,617.50",
    "mcapval": "42,872.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE068V01023",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "03:27 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "3.36 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4139579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlandPharmaLtd_mojoScore_4139579.png",
        "date": "2026-08-06 10:11:57",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gland Pharma Ltd Valuation Shifts to Very Expensive Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-valuation-shifts-to-very-expensive-amid-strong-market-performance-4136950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlandPharmaLtd_valuationdot_4136950.png",
        "date": "2026-08-05 08:03:33",
        "description": "Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex benchmark. This change reflects evolving market perceptions and valuation multiples in the Pharmaceuticals & Biotechnology sector, prompting investors to reassess the stock’s price attractiveness in the context of its financial performance and peer comparisons."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2599.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs259985-4135202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlandPharmaLtd_priceRelatedfactors_4135202.png",
        "date": "2026-08-04 09:50:04",
        "description": "With a decisive surge to Rs 2599.85 on 4 Aug 2026, Gland Pharma Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and broader market peers."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2585.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs258555-4128412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4128412.png",
        "date": "2026-07-30 10:08:19",
        "description": "Surging to a new 52-week high of Rs 2,585.55 on 30 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market with a 24.7% gain over the past year against the Sensex’s decline of 4.6%. This milestone reflects a confluence of technical signals aligning favourably across multiple timeframes, underscoring the stock’s sustained upward trajectory."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4121074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4121074.png",
        "date": "2026-07-26 10:10:29",
        "description": "Gland Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4103623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4103623.png",
        "date": "2026-07-15 10:11:02",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2574",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs2574-4093213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4093213.png",
        "date": "2026-07-08 09:49:07",
        "description": "With a decisive breakthrough to Rs 2,574 on 8 Jul 2026, Gland Pharma Ltd has reached a fresh 52-week high, extending its impressive 34.09% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2535",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs2535-4092098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_priceRelatedfactors_4092098.png",
        "date": "2026-07-07 10:07:53",
        "description": "Surging to a fresh 52-week high of Rs 2,535 on 7 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market. This milestone caps a year-long rally that has delivered a 34.43% return, significantly outperforming the Sensex’s decline of 5.99% over the same period."
      },
      {
        "title": "Gland Pharma Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4088302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlandPharmaLtd_mojoScore_4088302.png",
        "date": "2026-07-04 10:10:33",
        "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 July 2026, providing investors with the most recent and relevant data to assess the company’s prospects."
      }
    ],
    "total": 408,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "05-Aug-2026",
      "details": "Gland Pharma announces strategic collaboration with Neuland Laboratories for sterile API Manufacturing",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Aug-2026",
      "details": "Copy of News paper Publication",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "31-Jul-2026",
      "details": "Annual Report for the FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "10 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>2000%</strong> dividend, ex-date: 11 Aug 26",
          "dt": "2026-08-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gland Pharma Ltd is Rated Buy

2026-08-06 10:11:57

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Gland Pharma Ltd Valuation Shifts to Very Expensive Amid Strong Market Performance

2026-08-05 08:03:33

Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex benchmark. This change reflects evolving market perceptions and valuation multiples in the Pharmaceuticals & Biotechnology sector, prompting investors to reassess the stock’s price attractiveness in the context of its financial performance and peer comparisons.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2599.85

2026-08-04 09:50:04

With a decisive surge to Rs 2599.85 on 4 Aug 2026, Gland Pharma Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and broader market peers.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2585.55

2026-07-30 10:08:19

Surging to a new 52-week high of Rs 2,585.55 on 30 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market with a 24.7% gain over the past year against the Sensex’s decline of 4.6%. This milestone reflects a confluence of technical signals aligning favourably across multiple timeframes, underscoring the stock’s sustained upward trajectory.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-26 10:10:29

Gland Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-15 10:11:02

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2574

2026-07-08 09:49:07

With a decisive breakthrough to Rs 2,574 on 8 Jul 2026, Gland Pharma Ltd has reached a fresh 52-week high, extending its impressive 34.09% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market.

Read full news article

Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2535

2026-07-07 10:07:53

Surging to a fresh 52-week high of Rs 2,535 on 7 Jul 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market. This milestone caps a year-long rally that has delivered a 34.43% return, significantly outperforming the Sensex’s decline of 5.99% over the same period.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-07-04 10:10:33

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 July 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Read full news article

View All News